Its immunologists, cell biologists, and business professionals have contributed to the growth and success of global companies for over 25 years.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Abeomics develops well-validated, specific antibodies using traditional hybridoma technology and genetic engineering, producing recombinant mouse and rabbit monoclonal antibodies.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 27, 2026 and September 29, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.
